{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:24Z","timestamp":1784549184594,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rpth.2026.106623","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:00:04Z","timestamp":1777942804000},"page":"106623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Menstrual outcomes are frequently overlooked in von Willebrand disease trials"],"prefix":"10.1016","volume":"10","author":[{"given":"Meaghan","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezan","family":"Abdul Kadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"D\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Elfvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Golan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Gouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Quintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin P.M.","family":"van Galen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2999-4216","authenticated-orcid":false,"given":"Michelle","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106623_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106623_bib2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/hae.14804","article-title":"Von Willebrand disease: gaining a global perspective","volume":"29","author":"O\u2019Sullivan","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/hae.13722","article-title":"Barriers and challenges faced by women with congenital bleeding disorders in Europe: results of a patient survey conducted by the European Haemophilia Consortium","volume":"25","author":"Noone","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib4","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106623_bib7","unstructured":"Canadian Clinical Trial Database. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/health-canada-clinical-trials-database.html [Accessed September 4, 2024]"},{"key":"10.1016\/j.rpth.2026.106623_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/hae.70001","article-title":"Are women welcome in haemophilia trials?","volume":"31","author":"O\u2019Donnell","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/hae.15122","article-title":"A core outcome set for prophylaxis and perioperative treatment of von Willebrand disease: the coreVWD initiative","volume":"30","author":"Clearfield","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib11","first-page":"2024","volume":"7","year":"2024","journal-title":"Minimize Menorrhagia in Women With Von Willebrand Disease (VWDMin) September"},{"key":"10.1016\/j.rpth.2026.106623_bib21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106623_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood.2021014810","article-title":"Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results","volume":"140","author":"Leebeek","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2026.106623_bib24","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1055\/s-0044-1787815","article-title":"Exposure\u2013response relationship between VWF\/FVIII activity and spontaneous bleeding events following recombinant VWF prophylaxis in severe VWD","volume":"8","author":"Leebeek","year":"2024","journal-title":"TH Open"},{"key":"10.1016\/j.rpth.2026.106623_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/bloodadvances.2023011742","article-title":"von Willebrand factor\/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease","volume":"8","author":"Sidonio","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2026.106623_bib26","article-title":"Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor\/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls\/women with von Willebrand disease","volume":"5","author":"Kiss","year":"2025","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.rpth.2026.106623_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/hae.14868","article-title":"An open-label, multi-centre, post-marketing study to assess the efficacy and safety of a plasma-derived VWF\/FVIII concentrate in patients with von Willebrand disease","volume":"30","author":"Miesbach","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib28","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1016\/S2352-3026(23)00119-9","article-title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","volume":"10","author":"Ragni","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.rpth.2026.106623_bib29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/hae.70127","article-title":"Prevalence and impact of heavy menstrual bleeding in women with von willebrand disease across age groups: a retrospective study","volume":"31","author":"Olsson","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2026.106623_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res Integr Peer Rev"},{"key":"10.1016\/j.rpth.2026.106623_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/whe.15.85","article-title":"Outcome measures for heavy menstrual bleeding","volume":"12","author":"Quinn","year":"2016","journal-title":"Womens Health (London)"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926032814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:25:13Z","timestamp":1784546713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926032814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2475037926032814"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106623","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menstrual outcomes are frequently overlooked in von Willebrand disease trials","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106623"}}